Regeneron Pharmaceuticals, Inc. REGN
NASDAQ · United States · Health Technology
$758.27+7.76 (+1.03%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | 14.29 | 10.16 | +40.7% | $4.29B | +12.4% | +9.7%$695.42→$762.63 |
| Q1 2026 | 2026-04-29 | 9.47 | 8.90 | +6.4% | — | — | -3.4%$731.77→$707.06 |
| Q4 2025 | 2026-01-30 | 11.44 | 10.75 | +6.4% | — | — | +0.7%$749.44→$755.02 |
| Q3 2025 | 2025-10-28 | 11.83 | 9.64 | +22.7% | — | — | +11.5%$585.31→$652.91 |
| Q2 2025 | 2025-08-01 | 12.89 | 8.44 | +52.7% | — | — | — |
| Q1 2025 | 2025-04-29 | 8.22 | 8.48 | -3.1% | — | — | — |
| Q4 2024 | 2025-02-04 | 12.07 | 11.19 | +7.9% | — | — | — |
| Q3 2024 | 2024-10-31 | 12.46 | 11.70 | +6.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.